nodes	percent_of_prediction	percent_of_DWPC	metapath
Pentosan Polysulfate—FGF1—hematologic cancer	0.371	0.591	CbGaD
Pentosan Polysulfate—FGF2—hematologic cancer	0.257	0.409	CbGaD
Pentosan Polysulfate—FGF1—hematopoietic system—hematologic cancer	0.00173	0.191	CbGeAlD
Pentosan Polysulfate—FGF2—lung—hematologic cancer	0.00135	0.149	CbGeAlD
Pentosan Polysulfate—FGF2—testis—hematologic cancer	0.00128	0.141	CbGeAlD
Pentosan Polysulfate—FGF1—blood—hematologic cancer	0.00115	0.126	CbGeAlD
Pentosan Polysulfate—FGF1—lung—hematologic cancer	0.00101	0.111	CbGeAlD
Pentosan Polysulfate—FGF1—testis—hematologic cancer	0.00095	0.105	CbGeAlD
Pentosan Polysulfate—FGF2—lymph node—hematologic cancer	0.000926	0.102	CbGeAlD
Pentosan Polysulfate—FGF1—lymph node—hematologic cancer	0.000688	0.0758	CbGeAlD
Pentosan Polysulfate—Rash—Alitretinoin—hematologic cancer	3.31e-05	0.000188	CcSEcCtD
Pentosan Polysulfate—Agitation—Prednisone—hematologic cancer	3.31e-05	0.000188	CcSEcCtD
Pentosan Polysulfate—Dermatitis—Alitretinoin—hematologic cancer	3.31e-05	0.000188	CcSEcCtD
Pentosan Polysulfate—Thrombocytopenia—Betamethasone—hematologic cancer	3.3e-05	0.000188	CcSEcCtD
Pentosan Polysulfate—Thrombocytopenia—Dexamethasone—hematologic cancer	3.3e-05	0.000188	CcSEcCtD
Pentosan Polysulfate—Vomiting—Ifosfamide—hematologic cancer	3.3e-05	0.000187	CcSEcCtD
Pentosan Polysulfate—Hypersensitivity—Cisplatin—hematologic cancer	3.3e-05	0.000187	CcSEcCtD
Pentosan Polysulfate—Headache—Alitretinoin—hematologic cancer	3.29e-05	0.000187	CcSEcCtD
Pentosan Polysulfate—Diarrhoea—Gemcitabine—hematologic cancer	3.28e-05	0.000187	CcSEcCtD
Pentosan Polysulfate—Nausea—Thalidomide—hematologic cancer	3.28e-05	0.000186	CcSEcCtD
Pentosan Polysulfate—Dyspepsia—Triamcinolone—hematologic cancer	3.27e-05	0.000186	CcSEcCtD
Pentosan Polysulfate—Rash—Ifosfamide—hematologic cancer	3.27e-05	0.000186	CcSEcCtD
Pentosan Polysulfate—Dermatitis—Ifosfamide—hematologic cancer	3.27e-05	0.000186	CcSEcCtD
Pentosan Polysulfate—Hyperhidrosis—Dexamethasone—hematologic cancer	3.26e-05	0.000185	CcSEcCtD
Pentosan Polysulfate—Hyperhidrosis—Betamethasone—hematologic cancer	3.26e-05	0.000185	CcSEcCtD
Pentosan Polysulfate—Dizziness—Irinotecan—hematologic cancer	3.26e-05	0.000185	CcSEcCtD
Pentosan Polysulfate—Urticaria—Etoposide—hematologic cancer	3.26e-05	0.000185	CcSEcCtD
Pentosan Polysulfate—Stomatitis—Doxorubicin—hematologic cancer	3.25e-05	0.000185	CcSEcCtD
Pentosan Polysulfate—Jaundice—Doxorubicin—hematologic cancer	3.25e-05	0.000185	CcSEcCtD
Pentosan Polysulfate—Malaise—Prednisone—hematologic cancer	3.25e-05	0.000184	CcSEcCtD
Pentosan Polysulfate—Rhinitis—Epirubicin—hematologic cancer	3.24e-05	0.000184	CcSEcCtD
Pentosan Polysulfate—Abdominal pain—Etoposide—hematologic cancer	3.24e-05	0.000184	CcSEcCtD
Pentosan Polysulfate—Conjunctivitis—Doxorubicin—hematologic cancer	3.24e-05	0.000184	CcSEcCtD
Pentosan Polysulfate—Tinnitus—Methotrexate—hematologic cancer	3.22e-05	0.000183	CcSEcCtD
Pentosan Polysulfate—Vomiting—Vincristine—hematologic cancer	3.22e-05	0.000183	CcSEcCtD
Pentosan Polysulfate—Anorexia—Dexamethasone—hematologic cancer	3.22e-05	0.000183	CcSEcCtD
Pentosan Polysulfate—Anorexia—Betamethasone—hematologic cancer	3.22e-05	0.000183	CcSEcCtD
Pentosan Polysulfate—Urticaria—Prednisolone—hematologic cancer	3.21e-05	0.000182	CcSEcCtD
Pentosan Polysulfate—Pharyngitis—Epirubicin—hematologic cancer	3.21e-05	0.000182	CcSEcCtD
Pentosan Polysulfate—Sweating—Doxorubicin—hematologic cancer	3.2e-05	0.000182	CcSEcCtD
Pentosan Polysulfate—Rash—Vincristine—hematologic cancer	3.19e-05	0.000181	CcSEcCtD
Pentosan Polysulfate—Dermatitis—Vincristine—hematologic cancer	3.19e-05	0.000181	CcSEcCtD
Pentosan Polysulfate—Haematuria—Doxorubicin—hematologic cancer	3.18e-05	0.000181	CcSEcCtD
Pentosan Polysulfate—Headache—Vincristine—hematologic cancer	3.17e-05	0.00018	CcSEcCtD
Pentosan Polysulfate—Nausea—Carmustine—hematologic cancer	3.15e-05	0.000179	CcSEcCtD
Pentosan Polysulfate—Epistaxis—Doxorubicin—hematologic cancer	3.14e-05	0.000179	CcSEcCtD
Pentosan Polysulfate—Vomiting—Mitoxantrone—hematologic cancer	3.13e-05	0.000178	CcSEcCtD
Pentosan Polysulfate—Vomiting—Irinotecan—hematologic cancer	3.13e-05	0.000178	CcSEcCtD
Pentosan Polysulfate—Sinusitis—Doxorubicin—hematologic cancer	3.13e-05	0.000178	CcSEcCtD
Pentosan Polysulfate—Nausea—Alitretinoin—hematologic cancer	3.12e-05	0.000177	CcSEcCtD
Pentosan Polysulfate—Rash—Irinotecan—hematologic cancer	3.11e-05	0.000177	CcSEcCtD
Pentosan Polysulfate—Rash—Mitoxantrone—hematologic cancer	3.11e-05	0.000177	CcSEcCtD
Pentosan Polysulfate—Dermatitis—Mitoxantrone—hematologic cancer	3.1e-05	0.000176	CcSEcCtD
Pentosan Polysulfate—Dermatitis—Irinotecan—hematologic cancer	3.1e-05	0.000176	CcSEcCtD
Pentosan Polysulfate—Headache—Mitoxantrone—hematologic cancer	3.09e-05	0.000175	CcSEcCtD
Pentosan Polysulfate—Headache—Irinotecan—hematologic cancer	3.09e-05	0.000175	CcSEcCtD
Pentosan Polysulfate—Nausea—Ifosfamide—hematologic cancer	3.08e-05	0.000175	CcSEcCtD
Pentosan Polysulfate—Musculoskeletal discomfort—Betamethasone—hematologic cancer	3.07e-05	0.000175	CcSEcCtD
Pentosan Polysulfate—Musculoskeletal discomfort—Dexamethasone—hematologic cancer	3.07e-05	0.000175	CcSEcCtD
Pentosan Polysulfate—Myalgia—Prednisone—hematologic cancer	3.06e-05	0.000174	CcSEcCtD
Pentosan Polysulfate—Arthralgia—Prednisone—hematologic cancer	3.06e-05	0.000174	CcSEcCtD
Pentosan Polysulfate—Feeling abnormal—Triamcinolone—hematologic cancer	3.06e-05	0.000174	CcSEcCtD
Pentosan Polysulfate—Diarrhoea—Cisplatin—hematologic cancer	3.06e-05	0.000174	CcSEcCtD
Pentosan Polysulfate—Alopecia—Methotrexate—hematologic cancer	3.05e-05	0.000173	CcSEcCtD
Pentosan Polysulfate—Vomiting—Gemcitabine—hematologic cancer	3.05e-05	0.000173	CcSEcCtD
Pentosan Polysulfate—Insomnia—Betamethasone—hematologic cancer	3.05e-05	0.000173	CcSEcCtD
Pentosan Polysulfate—Insomnia—Dexamethasone—hematologic cancer	3.05e-05	0.000173	CcSEcCtD
Pentosan Polysulfate—Paraesthesia—Betamethasone—hematologic cancer	3.03e-05	0.000172	CcSEcCtD
Pentosan Polysulfate—Paraesthesia—Dexamethasone—hematologic cancer	3.03e-05	0.000172	CcSEcCtD
Pentosan Polysulfate—Discomfort—Prednisone—hematologic cancer	3.03e-05	0.000172	CcSEcCtD
Pentosan Polysulfate—Rash—Gemcitabine—hematologic cancer	3.03e-05	0.000172	CcSEcCtD
Pentosan Polysulfate—Dermatitis—Gemcitabine—hematologic cancer	3.02e-05	0.000172	CcSEcCtD
Pentosan Polysulfate—Hypersensitivity—Etoposide—hematologic cancer	3.02e-05	0.000172	CcSEcCtD
Pentosan Polysulfate—Tinnitus—Epirubicin—hematologic cancer	3.01e-05	0.000171	CcSEcCtD
Pentosan Polysulfate—Headache—Gemcitabine—hematologic cancer	3.01e-05	0.000171	CcSEcCtD
Pentosan Polysulfate—Nausea—Vincristine—hematologic cancer	3.01e-05	0.000171	CcSEcCtD
Pentosan Polysulfate—Rhinitis—Doxorubicin—hematologic cancer	3e-05	0.00017	CcSEcCtD
Pentosan Polysulfate—Hypersensitivity—Prednisolone—hematologic cancer	2.98e-05	0.000169	CcSEcCtD
Pentosan Polysulfate—Pharyngitis—Doxorubicin—hematologic cancer	2.97e-05	0.000169	CcSEcCtD
Pentosan Polysulfate—Dyspepsia—Dexamethasone—hematologic cancer	2.97e-05	0.000169	CcSEcCtD
Pentosan Polysulfate—Dyspepsia—Betamethasone—hematologic cancer	2.97e-05	0.000169	CcSEcCtD
Pentosan Polysulfate—Urticaria—Triamcinolone—hematologic cancer	2.95e-05	0.000168	CcSEcCtD
Pentosan Polysulfate—Oedema—Prednisone—hematologic cancer	2.94e-05	0.000167	CcSEcCtD
Pentosan Polysulfate—Decreased appetite—Dexamethasone—hematologic cancer	2.93e-05	0.000167	CcSEcCtD
Pentosan Polysulfate—Decreased appetite—Betamethasone—hematologic cancer	2.93e-05	0.000167	CcSEcCtD
Pentosan Polysulfate—Nausea—Mitoxantrone—hematologic cancer	2.93e-05	0.000166	CcSEcCtD
Pentosan Polysulfate—Nausea—Irinotecan—hematologic cancer	2.93e-05	0.000166	CcSEcCtD
Pentosan Polysulfate—Infection—Prednisone—hematologic cancer	2.92e-05	0.000166	CcSEcCtD
Pentosan Polysulfate—Pruritus—Etoposide—hematologic cancer	2.9e-05	0.000165	CcSEcCtD
Pentosan Polysulfate—Alopecia—Epirubicin—hematologic cancer	2.86e-05	0.000162	CcSEcCtD
Pentosan Polysulfate—Nausea—Gemcitabine—hematologic cancer	2.85e-05	0.000162	CcSEcCtD
Pentosan Polysulfate—Vomiting—Cisplatin—hematologic cancer	2.84e-05	0.000162	CcSEcCtD
Pentosan Polysulfate—Hyperhidrosis—Prednisone—hematologic cancer	2.84e-05	0.000161	CcSEcCtD
Pentosan Polysulfate—Rash—Cisplatin—hematologic cancer	2.82e-05	0.00016	CcSEcCtD
Pentosan Polysulfate—Dermatitis—Cisplatin—hematologic cancer	2.82e-05	0.00016	CcSEcCtD
Pentosan Polysulfate—Diarrhoea—Etoposide—hematologic cancer	2.8e-05	0.000159	CcSEcCtD
Pentosan Polysulfate—Anorexia—Prednisone—hematologic cancer	2.8e-05	0.000159	CcSEcCtD
Pentosan Polysulfate—Ill-defined disorder—Methotrexate—hematologic cancer	2.79e-05	0.000159	CcSEcCtD
Pentosan Polysulfate—Tinnitus—Doxorubicin—hematologic cancer	2.79e-05	0.000158	CcSEcCtD
Pentosan Polysulfate—Anaemia—Methotrexate—hematologic cancer	2.78e-05	0.000158	CcSEcCtD
Pentosan Polysulfate—Feeling abnormal—Dexamethasone—hematologic cancer	2.78e-05	0.000158	CcSEcCtD
Pentosan Polysulfate—Feeling abnormal—Betamethasone—hematologic cancer	2.78e-05	0.000158	CcSEcCtD
Pentosan Polysulfate—Flatulence—Epirubicin—hematologic cancer	2.77e-05	0.000158	CcSEcCtD
Pentosan Polysulfate—Gastrointestinal pain—Dexamethasone—hematologic cancer	2.76e-05	0.000157	CcSEcCtD
Pentosan Polysulfate—Gastrointestinal pain—Betamethasone—hematologic cancer	2.76e-05	0.000157	CcSEcCtD
Pentosan Polysulfate—Hypersensitivity—Triamcinolone—hematologic cancer	2.74e-05	0.000156	CcSEcCtD
Pentosan Polysulfate—Malaise—Methotrexate—hematologic cancer	2.71e-05	0.000154	CcSEcCtD
Pentosan Polysulfate—Dizziness—Etoposide—hematologic cancer	2.71e-05	0.000154	CcSEcCtD
Pentosan Polysulfate—Leukopenia—Methotrexate—hematologic cancer	2.69e-05	0.000153	CcSEcCtD
Pentosan Polysulfate—Urticaria—Dexamethasone—hematologic cancer	2.68e-05	0.000152	CcSEcCtD
Pentosan Polysulfate—Urticaria—Betamethasone—hematologic cancer	2.68e-05	0.000152	CcSEcCtD
Pentosan Polysulfate—Musculoskeletal discomfort—Prednisone—hematologic cancer	2.68e-05	0.000152	CcSEcCtD
Pentosan Polysulfate—Dizziness—Prednisolone—hematologic cancer	2.67e-05	0.000152	CcSEcCtD
Pentosan Polysulfate—Abdominal pain—Betamethasone—hematologic cancer	2.67e-05	0.000151	CcSEcCtD
Pentosan Polysulfate—Abdominal pain—Dexamethasone—hematologic cancer	2.67e-05	0.000151	CcSEcCtD
Pentosan Polysulfate—Nausea—Cisplatin—hematologic cancer	2.66e-05	0.000151	CcSEcCtD
Pentosan Polysulfate—Insomnia—Prednisone—hematologic cancer	2.66e-05	0.000151	CcSEcCtD
Pentosan Polysulfate—Alopecia—Doxorubicin—hematologic cancer	2.64e-05	0.00015	CcSEcCtD
Pentosan Polysulfate—Paraesthesia—Prednisone—hematologic cancer	2.64e-05	0.00015	CcSEcCtD
Pentosan Polysulfate—Pruritus—Triamcinolone—hematologic cancer	2.63e-05	0.000149	CcSEcCtD
Pentosan Polysulfate—Ill-defined disorder—Epirubicin—hematologic cancer	2.61e-05	0.000148	CcSEcCtD
Pentosan Polysulfate—Vomiting—Etoposide—hematologic cancer	2.61e-05	0.000148	CcSEcCtD
Pentosan Polysulfate—Anaemia—Epirubicin—hematologic cancer	2.6e-05	0.000148	CcSEcCtD
Pentosan Polysulfate—Agitation—Epirubicin—hematologic cancer	2.59e-05	0.000147	CcSEcCtD
Pentosan Polysulfate—Dyspepsia—Prednisone—hematologic cancer	2.59e-05	0.000147	CcSEcCtD
Pentosan Polysulfate—Rash—Etoposide—hematologic cancer	2.58e-05	0.000147	CcSEcCtD
Pentosan Polysulfate—Dermatitis—Etoposide—hematologic cancer	2.58e-05	0.000147	CcSEcCtD
Pentosan Polysulfate—Headache—Etoposide—hematologic cancer	2.57e-05	0.000146	CcSEcCtD
Pentosan Polysulfate—Flatulence—Doxorubicin—hematologic cancer	2.57e-05	0.000146	CcSEcCtD
Pentosan Polysulfate—Arthralgia—Methotrexate—hematologic cancer	2.56e-05	0.000145	CcSEcCtD
Pentosan Polysulfate—Myalgia—Methotrexate—hematologic cancer	2.56e-05	0.000145	CcSEcCtD
Pentosan Polysulfate—Decreased appetite—Prednisone—hematologic cancer	2.55e-05	0.000145	CcSEcCtD
Pentosan Polysulfate—Rash—Prednisolone—hematologic cancer	2.55e-05	0.000145	CcSEcCtD
Pentosan Polysulfate—Dermatitis—Prednisolone—hematologic cancer	2.55e-05	0.000145	CcSEcCtD
Pentosan Polysulfate—Malaise—Epirubicin—hematologic cancer	2.54e-05	0.000144	CcSEcCtD
Pentosan Polysulfate—Headache—Prednisolone—hematologic cancer	2.53e-05	0.000144	CcSEcCtD
Pentosan Polysulfate—Discomfort—Methotrexate—hematologic cancer	2.53e-05	0.000144	CcSEcCtD
Pentosan Polysulfate—Leukopenia—Epirubicin—hematologic cancer	2.52e-05	0.000143	CcSEcCtD
Pentosan Polysulfate—Constipation—Prednisone—hematologic cancer	2.51e-05	0.000143	CcSEcCtD
Pentosan Polysulfate—Dizziness—Triamcinolone—hematologic cancer	2.46e-05	0.00014	CcSEcCtD
Pentosan Polysulfate—Infection—Methotrexate—hematologic cancer	2.44e-05	0.000139	CcSEcCtD
Pentosan Polysulfate—Nausea—Etoposide—hematologic cancer	2.43e-05	0.000138	CcSEcCtD
Pentosan Polysulfate—Feeling abnormal—Prednisone—hematologic cancer	2.42e-05	0.000138	CcSEcCtD
Pentosan Polysulfate—Ill-defined disorder—Doxorubicin—hematologic cancer	2.42e-05	0.000137	CcSEcCtD
Pentosan Polysulfate—Anaemia—Doxorubicin—hematologic cancer	2.41e-05	0.000137	CcSEcCtD
Pentosan Polysulfate—Thrombocytopenia—Methotrexate—hematologic cancer	2.4e-05	0.000137	CcSEcCtD
Pentosan Polysulfate—Gastrointestinal pain—Prednisone—hematologic cancer	2.4e-05	0.000136	CcSEcCtD
Pentosan Polysulfate—Nausea—Prednisolone—hematologic cancer	2.4e-05	0.000136	CcSEcCtD
Pentosan Polysulfate—Myalgia—Epirubicin—hematologic cancer	2.4e-05	0.000136	CcSEcCtD
Pentosan Polysulfate—Arthralgia—Epirubicin—hematologic cancer	2.4e-05	0.000136	CcSEcCtD
Pentosan Polysulfate—Agitation—Doxorubicin—hematologic cancer	2.39e-05	0.000136	CcSEcCtD
Pentosan Polysulfate—Pruritus—Betamethasone—hematologic cancer	2.39e-05	0.000136	CcSEcCtD
Pentosan Polysulfate—Pruritus—Dexamethasone—hematologic cancer	2.39e-05	0.000136	CcSEcCtD
Pentosan Polysulfate—Hyperhidrosis—Methotrexate—hematologic cancer	2.37e-05	0.000135	CcSEcCtD
Pentosan Polysulfate—Discomfort—Epirubicin—hematologic cancer	2.37e-05	0.000135	CcSEcCtD
Pentosan Polysulfate—Vomiting—Triamcinolone—hematologic cancer	2.36e-05	0.000134	CcSEcCtD
Pentosan Polysulfate—Malaise—Doxorubicin—hematologic cancer	2.35e-05	0.000133	CcSEcCtD
Pentosan Polysulfate—Rash—Triamcinolone—hematologic cancer	2.34e-05	0.000133	CcSEcCtD
Pentosan Polysulfate—Dermatitis—Triamcinolone—hematologic cancer	2.34e-05	0.000133	CcSEcCtD
Pentosan Polysulfate—Anorexia—Methotrexate—hematologic cancer	2.34e-05	0.000133	CcSEcCtD
Pentosan Polysulfate—Urticaria—Prednisone—hematologic cancer	2.33e-05	0.000133	CcSEcCtD
Pentosan Polysulfate—Leukopenia—Doxorubicin—hematologic cancer	2.33e-05	0.000132	CcSEcCtD
Pentosan Polysulfate—Headache—Triamcinolone—hematologic cancer	2.33e-05	0.000132	CcSEcCtD
Pentosan Polysulfate—Abdominal pain—Prednisone—hematologic cancer	2.32e-05	0.000132	CcSEcCtD
Pentosan Polysulfate—Diarrhoea—Dexamethasone—hematologic cancer	2.31e-05	0.000131	CcSEcCtD
Pentosan Polysulfate—Diarrhoea—Betamethasone—hematologic cancer	2.31e-05	0.000131	CcSEcCtD
Pentosan Polysulfate—Oedema—Epirubicin—hematologic cancer	2.3e-05	0.000131	CcSEcCtD
Pentosan Polysulfate—Infection—Epirubicin—hematologic cancer	2.28e-05	0.00013	CcSEcCtD
Pentosan Polysulfate—Thrombocytopenia—Epirubicin—hematologic cancer	2.25e-05	0.000128	CcSEcCtD
Pentosan Polysulfate—Musculoskeletal discomfort—Methotrexate—hematologic cancer	2.24e-05	0.000127	CcSEcCtD
Pentosan Polysulfate—Dizziness—Dexamethasone—hematologic cancer	2.23e-05	0.000127	CcSEcCtD
Pentosan Polysulfate—Dizziness—Betamethasone—hematologic cancer	2.23e-05	0.000127	CcSEcCtD
Pentosan Polysulfate—Hyperhidrosis—Epirubicin—hematologic cancer	2.22e-05	0.000126	CcSEcCtD
Pentosan Polysulfate—Insomnia—Methotrexate—hematologic cancer	2.22e-05	0.000126	CcSEcCtD
Pentosan Polysulfate—Arthralgia—Doxorubicin—hematologic cancer	2.22e-05	0.000126	CcSEcCtD
Pentosan Polysulfate—Myalgia—Doxorubicin—hematologic cancer	2.22e-05	0.000126	CcSEcCtD
Pentosan Polysulfate—Nausea—Triamcinolone—hematologic cancer	2.21e-05	0.000125	CcSEcCtD
Pentosan Polysulfate—Paraesthesia—Methotrexate—hematologic cancer	2.2e-05	0.000125	CcSEcCtD
Pentosan Polysulfate—Discomfort—Doxorubicin—hematologic cancer	2.19e-05	0.000124	CcSEcCtD
Pentosan Polysulfate—Anorexia—Epirubicin—hematologic cancer	2.19e-05	0.000124	CcSEcCtD
Pentosan Polysulfate—Dyspnoea—Methotrexate—hematologic cancer	2.19e-05	0.000124	CcSEcCtD
Pentosan Polysulfate—Hypersensitivity—Prednisone—hematologic cancer	2.16e-05	0.000123	CcSEcCtD
Pentosan Polysulfate—Dyspepsia—Methotrexate—hematologic cancer	2.16e-05	0.000123	CcSEcCtD
Pentosan Polysulfate—Vomiting—Dexamethasone—hematologic cancer	2.14e-05	0.000122	CcSEcCtD
Pentosan Polysulfate—Vomiting—Betamethasone—hematologic cancer	2.14e-05	0.000122	CcSEcCtD
Pentosan Polysulfate—Decreased appetite—Methotrexate—hematologic cancer	2.13e-05	0.000121	CcSEcCtD
Pentosan Polysulfate—Rash—Dexamethasone—hematologic cancer	2.13e-05	0.000121	CcSEcCtD
Pentosan Polysulfate—Rash—Betamethasone—hematologic cancer	2.13e-05	0.000121	CcSEcCtD
Pentosan Polysulfate—Oedema—Doxorubicin—hematologic cancer	2.13e-05	0.000121	CcSEcCtD
Pentosan Polysulfate—Dermatitis—Dexamethasone—hematologic cancer	2.12e-05	0.000121	CcSEcCtD
Pentosan Polysulfate—Dermatitis—Betamethasone—hematologic cancer	2.12e-05	0.000121	CcSEcCtD
Pentosan Polysulfate—Headache—Dexamethasone—hematologic cancer	2.11e-05	0.00012	CcSEcCtD
Pentosan Polysulfate—Headache—Betamethasone—hematologic cancer	2.11e-05	0.00012	CcSEcCtD
Pentosan Polysulfate—Infection—Doxorubicin—hematologic cancer	2.11e-05	0.00012	CcSEcCtD
Pentosan Polysulfate—Musculoskeletal discomfort—Epirubicin—hematologic cancer	2.09e-05	0.000119	CcSEcCtD
Pentosan Polysulfate—Thrombocytopenia—Doxorubicin—hematologic cancer	2.08e-05	0.000118	CcSEcCtD
Pentosan Polysulfate—Pruritus—Prednisone—hematologic cancer	2.08e-05	0.000118	CcSEcCtD
Pentosan Polysulfate—Insomnia—Epirubicin—hematologic cancer	2.08e-05	0.000118	CcSEcCtD
Pentosan Polysulfate—Paraesthesia—Epirubicin—hematologic cancer	2.06e-05	0.000117	CcSEcCtD
Pentosan Polysulfate—Hyperhidrosis—Doxorubicin—hematologic cancer	2.05e-05	0.000117	CcSEcCtD
Pentosan Polysulfate—Dyspnoea—Epirubicin—hematologic cancer	2.05e-05	0.000116	CcSEcCtD
Pentosan Polysulfate—Anorexia—Doxorubicin—hematologic cancer	2.03e-05	0.000115	CcSEcCtD
Pentosan Polysulfate—Feeling abnormal—Methotrexate—hematologic cancer	2.02e-05	0.000115	CcSEcCtD
Pentosan Polysulfate—Dyspepsia—Epirubicin—hematologic cancer	2.02e-05	0.000115	CcSEcCtD
Pentosan Polysulfate—Diarrhoea—Prednisone—hematologic cancer	2.01e-05	0.000114	CcSEcCtD
Pentosan Polysulfate—Gastrointestinal pain—Methotrexate—hematologic cancer	2.01e-05	0.000114	CcSEcCtD
Pentosan Polysulfate—Nausea—Dexamethasone—hematologic cancer	2e-05	0.000114	CcSEcCtD
Pentosan Polysulfate—Nausea—Betamethasone—hematologic cancer	2e-05	0.000114	CcSEcCtD
Pentosan Polysulfate—Decreased appetite—Epirubicin—hematologic cancer	2e-05	0.000113	CcSEcCtD
Pentosan Polysulfate—Constipation—Epirubicin—hematologic cancer	1.96e-05	0.000112	CcSEcCtD
Pentosan Polysulfate—Urticaria—Methotrexate—hematologic cancer	1.95e-05	0.000111	CcSEcCtD
Pentosan Polysulfate—Dizziness—Prednisone—hematologic cancer	1.94e-05	0.00011	CcSEcCtD
Pentosan Polysulfate—Abdominal pain—Methotrexate—hematologic cancer	1.94e-05	0.00011	CcSEcCtD
Pentosan Polysulfate—Musculoskeletal discomfort—Doxorubicin—hematologic cancer	1.94e-05	0.00011	CcSEcCtD
Pentosan Polysulfate—Insomnia—Doxorubicin—hematologic cancer	1.92e-05	0.000109	CcSEcCtD
Pentosan Polysulfate—Paraesthesia—Doxorubicin—hematologic cancer	1.91e-05	0.000108	CcSEcCtD
Pentosan Polysulfate—Dyspnoea—Doxorubicin—hematologic cancer	1.9e-05	0.000108	CcSEcCtD
Pentosan Polysulfate—Feeling abnormal—Epirubicin—hematologic cancer	1.89e-05	0.000108	CcSEcCtD
Pentosan Polysulfate—Gastrointestinal pain—Epirubicin—hematologic cancer	1.88e-05	0.000107	CcSEcCtD
Pentosan Polysulfate—Dyspepsia—Doxorubicin—hematologic cancer	1.87e-05	0.000106	CcSEcCtD
Pentosan Polysulfate—Vomiting—Prednisone—hematologic cancer	1.87e-05	0.000106	CcSEcCtD
Pentosan Polysulfate—Rash—Prednisone—hematologic cancer	1.85e-05	0.000105	CcSEcCtD
Pentosan Polysulfate—Dermatitis—Prednisone—hematologic cancer	1.85e-05	0.000105	CcSEcCtD
Pentosan Polysulfate—Decreased appetite—Doxorubicin—hematologic cancer	1.85e-05	0.000105	CcSEcCtD
Pentosan Polysulfate—Headache—Prednisone—hematologic cancer	1.84e-05	0.000105	CcSEcCtD
Pentosan Polysulfate—Urticaria—Epirubicin—hematologic cancer	1.83e-05	0.000104	CcSEcCtD
Pentosan Polysulfate—Constipation—Doxorubicin—hematologic cancer	1.82e-05	0.000103	CcSEcCtD
Pentosan Polysulfate—Abdominal pain—Epirubicin—hematologic cancer	1.82e-05	0.000103	CcSEcCtD
Pentosan Polysulfate—Hypersensitivity—Methotrexate—hematologic cancer	1.81e-05	0.000103	CcSEcCtD
Pentosan Polysulfate—Feeling abnormal—Doxorubicin—hematologic cancer	1.75e-05	9.95e-05	CcSEcCtD
Pentosan Polysulfate—Nausea—Prednisone—hematologic cancer	1.74e-05	9.91e-05	CcSEcCtD
Pentosan Polysulfate—Gastrointestinal pain—Doxorubicin—hematologic cancer	1.74e-05	9.88e-05	CcSEcCtD
Pentosan Polysulfate—Pruritus—Methotrexate—hematologic cancer	1.74e-05	9.87e-05	CcSEcCtD
Pentosan Polysulfate—Hypersensitivity—Epirubicin—hematologic cancer	1.69e-05	9.62e-05	CcSEcCtD
Pentosan Polysulfate—Urticaria—Doxorubicin—hematologic cancer	1.69e-05	9.59e-05	CcSEcCtD
Pentosan Polysulfate—Abdominal pain—Doxorubicin—hematologic cancer	1.68e-05	9.55e-05	CcSEcCtD
Pentosan Polysulfate—Diarrhoea—Methotrexate—hematologic cancer	1.68e-05	9.54e-05	CcSEcCtD
Pentosan Polysulfate—Pruritus—Epirubicin—hematologic cancer	1.63e-05	9.23e-05	CcSEcCtD
Pentosan Polysulfate—Dizziness—Methotrexate—hematologic cancer	1.62e-05	9.22e-05	CcSEcCtD
Pentosan Polysulfate—Diarrhoea—Epirubicin—hematologic cancer	1.57e-05	8.93e-05	CcSEcCtD
Pentosan Polysulfate—Hypersensitivity—Doxorubicin—hematologic cancer	1.57e-05	8.9e-05	CcSEcCtD
Pentosan Polysulfate—Vomiting—Methotrexate—hematologic cancer	1.56e-05	8.87e-05	CcSEcCtD
Pentosan Polysulfate—Rash—Methotrexate—hematologic cancer	1.55e-05	8.79e-05	CcSEcCtD
Pentosan Polysulfate—Dermatitis—Methotrexate—hematologic cancer	1.55e-05	8.79e-05	CcSEcCtD
Pentosan Polysulfate—Headache—Methotrexate—hematologic cancer	1.54e-05	8.74e-05	CcSEcCtD
Pentosan Polysulfate—Dizziness—Epirubicin—hematologic cancer	1.52e-05	8.63e-05	CcSEcCtD
Pentosan Polysulfate—Pruritus—Doxorubicin—hematologic cancer	1.5e-05	8.54e-05	CcSEcCtD
Pentosan Polysulfate—Vomiting—Epirubicin—hematologic cancer	1.46e-05	8.3e-05	CcSEcCtD
Pentosan Polysulfate—Nausea—Methotrexate—hematologic cancer	1.46e-05	8.28e-05	CcSEcCtD
Pentosan Polysulfate—Diarrhoea—Doxorubicin—hematologic cancer	1.45e-05	8.26e-05	CcSEcCtD
Pentosan Polysulfate—Rash—Epirubicin—hematologic cancer	1.45e-05	8.23e-05	CcSEcCtD
Pentosan Polysulfate—Dermatitis—Epirubicin—hematologic cancer	1.45e-05	8.22e-05	CcSEcCtD
Pentosan Polysulfate—Headache—Epirubicin—hematologic cancer	1.44e-05	8.18e-05	CcSEcCtD
Pentosan Polysulfate—Dizziness—Doxorubicin—hematologic cancer	1.41e-05	7.99e-05	CcSEcCtD
Pentosan Polysulfate—Nausea—Epirubicin—hematologic cancer	1.36e-05	7.75e-05	CcSEcCtD
Pentosan Polysulfate—Vomiting—Doxorubicin—hematologic cancer	1.35e-05	7.68e-05	CcSEcCtD
Pentosan Polysulfate—Rash—Doxorubicin—hematologic cancer	1.34e-05	7.62e-05	CcSEcCtD
Pentosan Polysulfate—Dermatitis—Doxorubicin—hematologic cancer	1.34e-05	7.61e-05	CcSEcCtD
Pentosan Polysulfate—Headache—Doxorubicin—hematologic cancer	1.33e-05	7.57e-05	CcSEcCtD
Pentosan Polysulfate—Nausea—Doxorubicin—hematologic cancer	1.26e-05	7.17e-05	CcSEcCtD
Pentosan Polysulfate—FGF2—Disease—BRAF—hematologic cancer	3.95e-06	2.12e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Immune System—MDM2—hematologic cancer	3.93e-06	2.11e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling Pathways—CSF2—hematologic cancer	3.92e-06	2.1e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling Pathways—FGF1—hematologic cancer	3.92e-06	2.1e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Disease—IL6R—hematologic cancer	3.9e-06	2.09e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Disease—CREBBP—hematologic cancer	3.9e-06	2.09e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Signaling Pathways—MTOR—hematologic cancer	3.9e-06	2.09e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Signaling Pathways—PIK3CB—hematologic cancer	3.9e-06	2.09e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Disease—FGF2—hematologic cancer	3.88e-06	2.08e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Signaling Pathways—IL2RA—hematologic cancer	3.87e-06	2.08e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling Pathways—FOXO1—hematologic cancer	3.86e-06	2.07e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling Pathways—PDGFRB—hematologic cancer	3.86e-06	2.07e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Adaptive Immune System—PIK3CA—hematologic cancer	3.85e-06	2.06e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Signaling Pathways—TERT—hematologic cancer	3.83e-06	2.05e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Disease—PIK3R1—hematologic cancer	3.83e-06	2.05e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Immune System—PIK3CB—hematologic cancer	3.83e-06	2.05e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Immune System—MTOR—hematologic cancer	3.83e-06	2.05e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Developmental Biology—HRAS—hematologic cancer	3.83e-06	2.05e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Immune System—CD4—hematologic cancer	3.82e-06	2.05e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Adaptive Immune System—KRAS—hematologic cancer	3.82e-06	2.05e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling Pathways—PDGFRA—hematologic cancer	3.8e-06	2.04e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling Pathways—JAK1—hematologic cancer	3.78e-06	2.03e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling Pathways—PRKCG—hematologic cancer	3.78e-06	2.03e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Immune System—PIK3R1—hematologic cancer	3.78e-06	2.03e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Signaling Pathways—PDGFB—hematologic cancer	3.74e-06	2e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Disease—MAP2K1—hematologic cancer	3.72e-06	1.99e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Disease—JAK2—hematologic cancer	3.72e-06	1.99e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Innate Immune System—HRAS—hematologic cancer	3.7e-06	1.99e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Disease—PIK3CD—hematologic cancer	3.7e-06	1.98e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Disease—KRAS—hematologic cancer	3.69e-06	1.98e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Immune System—PIK3CA—hematologic cancer	3.67e-06	1.97e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Immune System—JAK2—hematologic cancer	3.67e-06	1.97e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Developmental Biology—IL6—hematologic cancer	3.66e-06	1.96e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Signaling Pathways—CDKN1B—hematologic cancer	3.66e-06	1.96e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Signaling Pathways—TSC2—hematologic cancer	3.66e-06	1.96e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Innate Immune System—PIK3CA—hematologic cancer	3.65e-06	1.96e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Immune System—BCL2—hematologic cancer	3.64e-06	1.95e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Disease—MDM2—hematologic cancer	3.63e-06	1.95e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Immune System—IFNG—hematologic cancer	3.61e-06	1.93e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Immune System—CDKN1B—hematologic cancer	3.59e-06	1.92e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Immune System—MDM2—hematologic cancer	3.59e-06	1.92e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Signaling Pathways—CASP3—hematologic cancer	3.58e-06	1.92e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Signaling Pathways—IL2—hematologic cancer	3.58e-06	1.92e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Adaptive Immune System—HRAS—hematologic cancer	3.56e-06	1.91e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Innate Immune System—IL6—hematologic cancer	3.55e-06	1.9e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling Pathways—IL2RA—hematologic cancer	3.53e-06	1.89e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Disease—MTOR—hematologic cancer	3.53e-06	1.89e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Disease—PIK3CB—hematologic cancer	3.53e-06	1.89e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Immune System—IL1B—hematologic cancer	3.53e-06	1.89e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Disease—CD4—hematologic cancer	3.53e-06	1.89e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Signaling Pathways—FGFR3—hematologic cancer	3.52e-06	1.88e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Immune System—IL2—hematologic cancer	3.51e-06	1.88e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Adaptive Immune System—PIK3CA—hematologic cancer	3.51e-06	1.88e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling Pathways—TERT—hematologic cancer	3.49e-06	1.87e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Disease—PIK3R1—hematologic cancer	3.49e-06	1.87e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Signaling Pathways—CCND1—hematologic cancer	3.49e-06	1.87e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Immune System—PIK3CB—hematologic cancer	3.49e-06	1.87e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Immune System—MTOR—hematologic cancer	3.49e-06	1.87e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Immune System—CD4—hematologic cancer	3.48e-06	1.87e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Signaling Pathways—JUN—hematologic cancer	3.48e-06	1.87e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Signaling Pathways—MAPK14—hematologic cancer	3.48e-06	1.87e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Immune System—JUN—hematologic cancer	3.42e-06	1.83e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Signaling Pathways—ESR1—hematologic cancer	3.42e-06	1.83e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling Pathways—PDGFB—hematologic cancer	3.41e-06	1.83e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Immune System—HRAS—hematologic cancer	3.4e-06	1.82e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Disease—PIK3CA—hematologic cancer	3.39e-06	1.82e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Disease—JAK2—hematologic cancer	3.39e-06	1.82e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Innate Immune System—HRAS—hematologic cancer	3.38e-06	1.81e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Developmental Biology—AKT1—hematologic cancer	3.38e-06	1.81e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Signaling Pathways—CDKN1A—hematologic cancer	3.38e-06	1.81e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Signaling Pathways—FN1—hematologic cancer	3.37e-06	1.81e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Signaling Pathways—PTEN—hematologic cancer	3.37e-06	1.81e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Signaling Pathways—NFKBIA—hematologic cancer	3.33e-06	1.79e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Signaling Pathways—BAD—hematologic cancer	3.33e-06	1.79e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling Pathways—TSC2—hematologic cancer	3.33e-06	1.79e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Disease—CDKN1B—hematologic cancer	3.31e-06	1.78e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Immune System—CDKN1A—hematologic cancer	3.31e-06	1.78e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Disease—MDM2—hematologic cancer	3.31e-06	1.77e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Immune System—PTEN—hematologic cancer	3.31e-06	1.77e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Signaling Pathways—NOTCH1—hematologic cancer	3.3e-06	1.77e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Signaling Pathways—MAPK8—hematologic cancer	3.29e-06	1.77e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Immune System—CDKN1B—hematologic cancer	3.27e-06	1.76e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Innate Immune System—AKT1—hematologic cancer	3.27e-06	1.75e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Immune System—IL6—hematologic cancer	3.25e-06	1.74e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Adaptive Immune System—HRAS—hematologic cancer	3.24e-06	1.74e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Immune System—MAPK8—hematologic cancer	3.23e-06	1.73e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Signaling Pathways—CD80—hematologic cancer	3.23e-06	1.73e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Innate Immune System—IL6—hematologic cancer	3.23e-06	1.73e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Signaling Pathways—KIT—hematologic cancer	3.23e-06	1.73e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Signaling Pathways—PIK3CG—hematologic cancer	3.23e-06	1.73e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Disease—MTOR—hematologic cancer	3.22e-06	1.73e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Disease—PIK3CB—hematologic cancer	3.22e-06	1.73e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Immune System—IL1B—hematologic cancer	3.22e-06	1.72e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Disease—CD4—hematologic cancer	3.22e-06	1.72e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Signaling Pathways—EP300—hematologic cancer	3.21e-06	1.72e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling Pathways—FGFR3—hematologic cancer	3.21e-06	1.72e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Immune System—IL2—hematologic cancer	3.2e-06	1.72e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling Pathways—MAPK14—hematologic cancer	3.17e-06	1.7e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Signaling Pathways—PTPN11—hematologic cancer	3.17e-06	1.7e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Immune System—EP300—hematologic cancer	3.15e-06	1.69e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Adaptive Immune System—AKT1—hematologic cancer	3.14e-06	1.68e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Disease—HRAS—hematologic cancer	3.14e-06	1.68e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Signaling Pathways—SRC—hematologic cancer	3.12e-06	1.67e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Immune System—JUN—hematologic cancer	3.12e-06	1.67e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling Pathways—ESR1—hematologic cancer	3.11e-06	1.67e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling Pathways—FN1—hematologic cancer	3.08e-06	1.65e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Signaling Pathways—CREB1—hematologic cancer	3.07e-06	1.65e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Immune System—SRC—hematologic cancer	3.07e-06	1.64e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Disease—CDKN1A—hematologic cancer	3.06e-06	1.64e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Disease—PTEN—hematologic cancer	3.05e-06	1.64e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Signaling Pathways—VEGFA—hematologic cancer	3.04e-06	1.63e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling Pathways—BAD—hematologic cancer	3.04e-06	1.63e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling Pathways—NFKBIA—hematologic cancer	3.04e-06	1.63e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Signaling Pathways—BRAF—hematologic cancer	3.03e-06	1.63e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Disease—CDKN1B—hematologic cancer	3.02e-06	1.62e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Immune System—CDKN1A—hematologic cancer	3.02e-06	1.62e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Immune System—PTEN—hematologic cancer	3.01e-06	1.62e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Signaling Pathways—STAT3—hematologic cancer	3.01e-06	1.61e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling Pathways—NOTCH1—hematologic cancer	3.01e-06	1.61e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Signaling Pathways—CCL2—hematologic cancer	3.01e-06	1.61e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Signaling Pathways—NRAS—hematologic cancer	3e-06	1.61e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Disease—IL6—hematologic cancer	3e-06	1.61e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Immune System—AKT1—hematologic cancer	3e-06	1.61e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Signaling Pathways—IL6R—hematologic cancer	3e-06	1.61e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Signaling Pathways—CREBBP—hematologic cancer	2.99e-06	1.6e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Innate Immune System—AKT1—hematologic cancer	2.98e-06	1.6e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Immune System—STAT3—hematologic cancer	2.96e-06	1.58e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Immune System—NRAS—hematologic cancer	2.95e-06	1.58e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Immune System—MAPK8—hematologic cancer	2.95e-06	1.58e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling Pathways—CD80—hematologic cancer	2.95e-06	1.58e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling Pathways—KIT—hematologic cancer	2.94e-06	1.58e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling Pathways—PIK3CG—hematologic cancer	2.94e-06	1.58e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Disease—EP300—hematologic cancer	2.91e-06	1.56e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling Pathways—PTPN11—hematologic cancer	2.89e-06	1.55e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Signaling Pathways—MAPK3—hematologic cancer	2.88e-06	1.54e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Immune System—EP300—hematologic cancer	2.88e-06	1.54e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Adaptive Immune System—AKT1—hematologic cancer	2.86e-06	1.54e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Signaling Pathways—MAP2K1—hematologic cancer	2.86e-06	1.53e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Signaling Pathways—PIK3CD—hematologic cancer	2.84e-06	1.52e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Disease—SRC—hematologic cancer	2.83e-06	1.52e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Immune System—MAPK3—hematologic cancer	2.82e-06	1.51e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling Pathways—CREB1—hematologic cancer	2.8e-06	1.5e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Signaling Pathways—MYC—hematologic cancer	2.8e-06	1.5e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Immune System—SRC—hematologic cancer	2.8e-06	1.5e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Signaling Pathways—TGFB1—hematologic cancer	2.79e-06	1.5e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Disease—CDKN1A—hematologic cancer	2.79e-06	1.5e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Disease—PTEN—hematologic cancer	2.78e-06	1.49e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Disease—AKT1—hematologic cancer	2.77e-06	1.49e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling Pathways—BRAF—hematologic cancer	2.77e-06	1.48e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling Pathways—CCL2—hematologic cancer	2.74e-06	1.47e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling Pathways—IL6R—hematologic cancer	2.73e-06	1.47e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Disease—STAT3—hematologic cancer	2.73e-06	1.46e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling Pathways—CREBBP—hematologic cancer	2.73e-06	1.46e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Disease—NRAS—hematologic cancer	2.72e-06	1.46e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Signaling Pathways—FGF2—hematologic cancer	2.72e-06	1.46e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Immune System—STAT3—hematologic cancer	2.7e-06	1.45e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Immune System—NRAS—hematologic cancer	2.69e-06	1.44e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Signaling Pathways—PIK3R1—hematologic cancer	2.68e-06	1.44e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Disease—EP300—hematologic cancer	2.65e-06	1.42e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Disease—MAPK3—hematologic cancer	2.61e-06	1.4e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling Pathways—MAP2K1—hematologic cancer	2.61e-06	1.4e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Signaling Pathways—JAK2—hematologic cancer	2.6e-06	1.4e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling Pathways—PIK3CD—hematologic cancer	2.59e-06	1.39e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Signaling Pathways—KRAS—hematologic cancer	2.59e-06	1.39e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Disease—SRC—hematologic cancer	2.58e-06	1.38e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Immune System—MAPK3—hematologic cancer	2.58e-06	1.38e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Signaling Pathways—MDM2—hematologic cancer	2.54e-06	1.36e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Immune System—KRAS—hematologic cancer	2.54e-06	1.36e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Disease—MYC—hematologic cancer	2.54e-06	1.36e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Disease—TGFB1—hematologic cancer	2.53e-06	1.36e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Disease—STAT3—hematologic cancer	2.49e-06	1.33e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Disease—NRAS—hematologic cancer	2.48e-06	1.33e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Signaling Pathways—MTOR—hematologic cancer	2.47e-06	1.33e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Signaling Pathways—PIK3CB—hematologic cancer	2.47e-06	1.33e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling Pathways—PIK3R1—hematologic cancer	2.44e-06	1.31e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Disease—MAPK3—hematologic cancer	2.38e-06	1.27e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Signaling Pathways—PIK3CA—hematologic cancer	2.38e-06	1.27e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling Pathways—JAK2—hematologic cancer	2.38e-06	1.27e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Disease—KRAS—hematologic cancer	2.34e-06	1.26e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Immune System—PIK3CA—hematologic cancer	2.33e-06	1.25e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Signaling Pathways—CDKN1B—hematologic cancer	2.32e-06	1.24e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling Pathways—MDM2—hematologic cancer	2.32e-06	1.24e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Immune System—KRAS—hematologic cancer	2.31e-06	1.24e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Disease—MYC—hematologic cancer	2.31e-06	1.24e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Disease—TGFB1—hematologic cancer	2.31e-06	1.24e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Signaling Pathways—TP53—hematologic cancer	2.3e-06	1.23e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Signaling Pathways—CASP3—hematologic cancer	2.28e-06	1.22e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Signaling Pathways—IL2—hematologic cancer	2.27e-06	1.22e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling Pathways—PIK3CB—hematologic cancer	2.26e-06	1.21e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling Pathways—MTOR—hematologic cancer	2.26e-06	1.21e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Signaling Pathways—CCND1—hematologic cancer	2.21e-06	1.19e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Signaling Pathways—JUN—hematologic cancer	2.21e-06	1.18e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Signaling Pathways—HRAS—hematologic cancer	2.2e-06	1.18e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Immune System—HRAS—hematologic cancer	2.16e-06	1.16e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Disease—PIK3CA—hematologic cancer	2.15e-06	1.15e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Signaling Pathways—CDKN1A—hematologic cancer	2.14e-06	1.15e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Signaling Pathways—PTEN—hematologic cancer	2.14e-06	1.15e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Disease—KRAS—hematologic cancer	2.14e-06	1.15e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Immune System—PIK3CA—hematologic cancer	2.13e-06	1.14e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling Pathways—CDKN1B—hematologic cancer	2.12e-06	1.13e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Signaling Pathways—IL6—hematologic cancer	2.1e-06	1.13e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Signaling Pathways—MAPK8—hematologic cancer	2.09e-06	1.12e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling Pathways—CASP3—hematologic cancer	2.07e-06	1.11e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling Pathways—IL2—hematologic cancer	2.07e-06	1.11e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Immune System—IL6—hematologic cancer	2.07e-06	1.11e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Signaling Pathways—EP300—hematologic cancer	2.04e-06	1.09e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling Pathways—CCND1—hematologic cancer	2.02e-06	1.08e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling Pathways—JUN—hematologic cancer	2.02e-06	1.08e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Disease—HRAS—hematologic cancer	1.99e-06	1.07e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Signaling Pathways—SRC—hematologic cancer	1.98e-06	1.06e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Immune System—HRAS—hematologic cancer	1.97e-06	1.05e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Disease—PIK3CA—hematologic cancer	1.96e-06	1.05e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling Pathways—CDKN1A—hematologic cancer	1.95e-06	1.05e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling Pathways—PTEN—hematologic cancer	1.95e-06	1.04e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Signaling Pathways—AKT1—hematologic cancer	1.94e-06	1.04e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Signaling Pathways—VEGFA—hematologic cancer	1.93e-06	1.03e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Signaling Pathways—STAT3—hematologic cancer	1.91e-06	1.02e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Signaling Pathways—NRAS—hematologic cancer	1.91e-06	1.02e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling Pathways—MAPK8—hematologic cancer	1.91e-06	1.02e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Disease—IL6—hematologic cancer	1.91e-06	1.02e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Immune System—AKT1—hematologic cancer	1.91e-06	1.02e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Immune System—IL6—hematologic cancer	1.88e-06	1.01e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling Pathways—EP300—hematologic cancer	1.86e-06	9.96e-06	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Signaling Pathways—MAPK3—hematologic cancer	1.83e-06	9.79e-06	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Disease—HRAS—hematologic cancer	1.82e-06	9.74e-06	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling Pathways—SRC—hematologic cancer	1.81e-06	9.69e-06	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Signaling Pathways—MYC—hematologic cancer	1.78e-06	9.52e-06	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Signaling Pathways—TGFB1—hematologic cancer	1.77e-06	9.5e-06	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling Pathways—VEGFA—hematologic cancer	1.76e-06	9.44e-06	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Disease—AKT1—hematologic cancer	1.76e-06	9.43e-06	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling Pathways—STAT3—hematologic cancer	1.74e-06	9.34e-06	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling Pathways—NRAS—hematologic cancer	1.74e-06	9.32e-06	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Disease—IL6—hematologic cancer	1.74e-06	9.32e-06	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Immune System—AKT1—hematologic cancer	1.74e-06	9.31e-06	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling Pathways—MAPK3—hematologic cancer	1.67e-06	8.93e-06	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Signaling Pathways—KRAS—hematologic cancer	1.64e-06	8.8e-06	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling Pathways—MYC—hematologic cancer	1.62e-06	8.68e-06	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling Pathways—TGFB1—hematologic cancer	1.62e-06	8.66e-06	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Disease—AKT1—hematologic cancer	1.6e-06	8.6e-06	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Signaling Pathways—PIK3CA—hematologic cancer	1.51e-06	8.08e-06	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling Pathways—KRAS—hematologic cancer	1.5e-06	8.02e-06	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Signaling Pathways—TP53—hematologic cancer	1.46e-06	7.82e-06	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Signaling Pathways—HRAS—hematologic cancer	1.4e-06	7.48e-06	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling Pathways—PIK3CA—hematologic cancer	1.38e-06	7.37e-06	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Signaling Pathways—IL6—hematologic cancer	1.34e-06	7.16e-06	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling Pathways—TP53—hematologic cancer	1.33e-06	7.13e-06	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling Pathways—HRAS—hematologic cancer	1.27e-06	6.82e-06	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Signaling Pathways—AKT1—hematologic cancer	1.23e-06	6.6e-06	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling Pathways—IL6—hematologic cancer	1.22e-06	6.53e-06	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling Pathways—AKT1—hematologic cancer	1.12e-06	6.02e-06	CbGpPWpGaD
